Search
for
Sort by
Research 61–90 of 1000+
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Exosome-Based Therapies for Alopecia: A Systematic Review of Clinical Efficacy and Safety
- Sunscreen: Cosmetic or medical therapy?
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Cutaneous toxicities of new treatments for melanoma
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Adverse events with finasteride or dutasteride: FAERS
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- Drug-induced hair colour changes
- 0348 Adverse event reports of alopecia for sunscreen ingredients and branded products
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Comment on “Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series”: Adding further evidence about side effects
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- Finasteride toxicity information: “limited”, “poor quality”, “biased”
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health